The European Society of Gene and Cell Therapy
Online/Digital
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe. Source
Actions
Media Outlet details
| Scope | National |
|---|---|
| Language | English |
| Country | United Kingdom |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesR2-I Recognised Researcher (Therapeutics and innovations in neuropediatrics) - Vall D'Hebron, Barcelona
Our terms and conditions for: User account Membership Copyright ©2023 European Society of Gene and Cell Therapy
SR-TIGET–Danaher Symposium, “Unlocking Access: Cell & Gene Therapy at Scale ” San Raffaele Hospital in Milan on 9–10 November 2026
SR-TIGET–Danaher Symposium, “Unlocking Access: Cell & Gene Therapy at Scale ” is taking place at San Raffaele Hospital in Milan on 9–10 November 2026, marking the 30th anniversary of SR-TIGET. The meeting will bring together leading researchers, clinicians, industry experts and patient representatives to discuss advances in hematopoietic stem cell gene therapy and genome editing, alongside key challenges in safety, manufacturing and sustainable patient access.
Priora is hiring – 5 scientific roles in immune-cell delivery for neurological disease, London, UK
Priora is an early-stage company building a delivery route for therapies to the brain, using engineered immune cells to reach specific cell subsets non-invasively. The team of ~15 researchers is based in London and San Francisco. Open roles, all London and full-time: VP of Translational Research; Senior Scientist, In Vivo Neuroscience; Senior Computational Scientist; Research Scientist, In Vitro; and Scientist, Mouse Models. Full details and application links for each role are on the careers page.
Postdoc – Advanced Viral Vector Technology & Bioprocess Development - Leuven, Belgium
Our research group, the Laboratory Molecular Vectorlogy and Gene Therapy (LMVGT) is part of ADVANTAGE labs (Advanced Disease Modeling, Targeted Drug Discovery and Gene Therapy), Dept. Pharmaceutical and Pharmacological Sciences, group Biomedical Sciences at KU Leuven, Belgium. Our mission is to advance viral vector engineering, technology development, production, and application for rare disease modelling and gene therapy.
T2EVOLVE Association Launches to Advance Collaboration and Innovation in Advanced Cell Therapies Across Europe
Our terms and conditions for: User account Membership Copyright ©2023 European Society of Gene and Cell Therapy
MSCA COFUND Postodoc Program BEYOND on Advanced Therapies
✨ We are pleased to share this exciting opportunity for postdoctoral researchers in advanced therapies. Applications are now open for BEYOND, a Marie Skłodowska-Curie Actions COFUND Postdoctoral Program in Advanced Therapies, co-funded by the European Union.
AMM-Only Project Pioneers Grant Programme 2026: Funding Innovative Research in Duchenne Muscular Dystrophy - Applications Now Open
AMM-Only Project, a Monaco-based association dedicated to advancing research in Duchenne muscular dystrophy (DMD) and related neuromuscular diseases, is pleased to announce the opening of applications for the 2026 edition of the Pioneers Grant Programme. Launched in 2025, the Pioneers Grant Programme was created to accelerate scientific discovery and the development of innovative therapeutic approaches for Duchenne muscular dystrophy and other neuromuscular disorders.
Help shape the future of gene & cell therapy policy in Europe
The European Society of Gene & Cell Therapy (ESGCT) is looking for a Public Affairs & Health Policy Lead to establish and drive its European policy and advocacy function.
2026-SPRING SCHOOL COIMBRA
Our terms and conditions for: User account Membership Copyright ©2023 European Society of Gene and Cell Therapy
GCure – University of Coimbra is recruiting a Group Leader in Gene Therapy
The University of Coimbra (Portugal) is recruiting a Group Leader / Principal Investigator to join GCure, an ERA Chair project funded by Horizon Europe (GA 101186929), focused on strengthening Europe’s capacity in advanced gene therapy development.